Author:
Nikolaus Susanne,Chao Owen Y.,Henke Jan,Beu Markus,Fazari Benedetta,Rodrigues Almeida Filipe,Abdel-Hafiz Laila,Antke Christina,Hautzel Hubertus,Mamlins Eduards,Müller HW,Huston Joseph P.,von Gall Charlotte,Giesel Frederik L.
Reference93 articles.
1. have 5-HT 2A R agonistic and antagonistic properties, respectively. In rats, systemic 5-HT 1A R agonist treatment with 8-OH-DPAT (0.05 and 0.1 mg/kg) did not alter DA levels in CP;Khawaja;globus pallidus (Hjorth and Sharp, 1991), dorsal and ventral HIPP (dHIPP and vHIPP; Nomikos et al., 1992; however, see M�ller et al., 2003), medial septum and RN (Hjorth and Sharp,1990
2. Systemic 5-HT 2A R agonist treatment with DOI (2 -5 mg/kg) did not alter DA levels in CP (Gudelsky et al., 1994, Ichikawa and Meltzer;M�ller;HT concentrations in NAC,1995
3. In vivo brain dialysis study of somatodendritic release of serotonin in the Raphe nuclei of the rat: effects of 8-hydroxy-2-(dib.propylamino)tetralin;A Adell;J. Neurochem,1993
4. Basal ganglia: functional anatomy and physiology. Part 1;A K Afifi;J. Child Neurol,1994
5. Basal ganglia: functional anatomy and physiology. Part 2;A K Afifi;J. Child Neurol,1994